| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0526 | Akr1c3-in-14a | Novel potent and selective aldo-keto reductase 1C3 inhibitor, displaying selectivity for AKR1C3 over other AKR1C enzymes and COX |
|
| DCC0527 | Akti-2 | Cell-permeable Akt1/2 inhibitor with improved solubility and Ak2 selectivity |
|
| DCC0528 | Al-34662 | Potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist |
|
| DCC0529 | Al-438 | Non-steroidal selective modulator for the glucocorticoid receptor (GR) |
|
| DCC0530 | Al-661 | Novel HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C |
|
| DCC0531 | Alalevonadifloxacin Mesylate | Novel anti-MRSA antibacterial agent, targeting infections caused by Gram-positive bacteria |
|
| DCC0532 | Ala-vpa Conjugate-1 | α-Linolenic acid-Valproic acid conjugate, not only modulating microglia polarization, but also counteracting neurodegeneration and demyelination and induce oligodendrocyte precursor cell differentiation, by acting on multiple biochemical and epigenetic pa |
|
| DCC0533 | Alazocine | Potent analgesic, psychotomimetic or hallucinogen, and morphine or opioid antagonist |
|
| DCC0534 | Albicidin | Potent DNA gyrase inhibitor |
|
| DCC0535 | Albiziabioside A | Natural antitumor agent, inducing caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway |
|
| DCC0536 | Albucidin | Novel nucleoside phytotoxin |
|
| DCC0537 | Alcuronium Chloride | Neuromuscular blocking (NMB) agent |
|
| DCC0538 | Alda-89 | Novel activator of ALDH3A1 |
|
| DCC0539 | Aldi-2 | Potent and specific covalent inhibitor of aldehyde dehydrogenases |
|
| DCC0540 | Aldi-6 Hydrochloride | Novel ALDH inhibitor, inhibiting ALDH3A1 activity in SCC4 HNSCC xenografts |
|
| DCC0541 | Aldoxorubicin | Prodrug of the anthracycline antibiotic doxorubicin, binding selectively to the cysteine-34 position of albumin via its maleimide moiety, inhibiting DNA synthesis, and inducing apoptosis |
|
| DCC0542 | Alk/ros1-in-7d | Potent and selective L1196M ALK and ROS1 dual inhibitor |
|
| DCC0543 | Alk-001 Featured | ALK-001 is a vitamin A analog potentially for the treatment of Stargardt’s disease. |
.gif)
|
| DCC0544 | Alk-gw9662 | Clickable PPARγ inhibitor |
|
| DCC0545 | Alkyne-a-dsbso Featured | Novel Enrichable and MS-Cleavable Cross-linker to Define Protein-Protein Interactions by Mass Spectrometry |
|
| DCC0546 | Gsk1360707f | Potent and selective triple reuptake inhibitor |
|
| DCC0547 | Allo-i1e-isoindoline | Irreversible and selective dipeptidyl peptidase 8 and 9 (DPP-8/9) inhibitor |
|
| DCC0548 | Allo-ile-isoindoline Hcl | Irreversible and selective dipeptidyl peptidase 8 and 9 (DPP-8/9) inhibitor |
|
| DCC0549 | Alloswitch-1 | Novel allosteric modulator to control endogenous G protein-coupled receptors with light |
|
| DCC0550 | Alloxan Hydrate [3237-50-1] | Natural chemical suppressor of mlo-mediated resistance in monocotyledonous barley (Hordeum vulgare) and dicotyledonous Arabidopsis thaliana |
|
| DCC0551 | Allylpyrocatechol | Antioxidant, attenuating collagen-induced arthritis via attenuation of oxidative stress secondary to modulation of the MAPK, JAK/STAT, and Nrf2/HO-1 pathways |
|
| DCC0552 | Alpha7-pam-3ea | Novel potent type I positive allosteric modulator (PAM) of human α7 nAChR |
|
| DCC0553 | Alpha-amplexichromanol | Highly potent, orally effective, and metabolically stable allosteric 5-LOX Inhibitor |
|
| DCC0554 | Alpha-br-tmc | Novel JAK2/STAT5 inhibitor |
|
| DCC0555 | Alpha-cf3-tmc | Novel inhibitor of JAK2 and STAT5 phosphorylation in response to interleukin-3 without altering STAT5 mobility in SDS-PAGE |
|
